1 year return (CAGR)
-44.12%
XTL Biopharmaceuticals Ltd ADR Exchange (NASDAQ, USD)
XTLB
2.38
+0.34 (+14.66%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-13.85%
5 year return (CAGR)
-32.40%
10 year return (CAGR)
-23.06%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
6.54M
Price/Sales
22.62
Ent value
6.88M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
153.22%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.51 |
| Daily high | 2.69 |
| Daily low | 2.33 |
| Daily Volume | 33K |
| All-time high | 2284.00 |
| 1y analyst estimate | 30.00 |
| Beta | 0.46 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| XTLB | S&P500 | |
| Current price drop from All-time high | -99.90% | -0.56% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 31 Dec 2025 | 9 Mar 2009 |
| Avg drop from high | -92.89% | -10.68% |
| Avg time to new high | 1556 days | 12 days |
| Max time to new high | 4665 days | 1805 days |
News
